Your browser doesn't support javascript.
Thrombotic Complications of COVID-19 Infection: A Review.
Castro, Rebecca A; Frishman, William H.
  • Castro RA; From the New York Medical College, Valhalla, NY.
  • Frishman WH; Department of Medicine, New York Medical College/Westchester Medical Center, Valhalla, NY.
Cardiol Rev ; 29(1): 43-47, 2021.
Artículo en Inglés | MEDLINE | ID: covidwho-965899
ABSTRACT
The novel coronavirus (severe acute respiratory syndrome CoV-2 [SARS-CoV-2]), also known as COVID-19, is a single-stranded enveloped RNA virus that created a Public Health Emergency of International Concern in January 2020, with a global case burden of over 15 million in just 7 months. Infected patients develop a wide range of clinical manifestations-typically presenting with fever, cough, myalgia, and fatigue. Severely ill patients may fall victim to acute respiratory distress syndrome, acute heart injuries, neurological manifestations, or complications due to secondary infections. These critically ill patients are also found to have disrupted coagulation function, predisposing them to consumptive coagulopathies, and both venous and thromboembolic complications. Common laboratory findings include thrombocytopenia, elevated D-dimer, fibrin degradation products, and fibrinogen, all of which have been associated with greater disease severity. Many cases of pulmonary embolism have been noted, along with deep vein thrombosis, ischemic stroke, myocardial infarction, and systemic arterial embolism. The pathogenesis of coronavirus has not been completely elucidated, but the virus is known to cause excessive inflammation, endothelial injury, hypoxia, and disseminated intravascular coagulation, all of which contribute to thrombosis formation. These patients are also faced with prolonged immobilization while staying in the hospital or intensive care unit. It is important to have a high degree of suspicion for thrombotic complications as patients may rapidly deteriorate in severe cases. Evidence suggests that prophylaxis with anticoagulation may lead to a lower risk of mortality, although it does not eliminate the possibility. The risks and benefits of anticoagulation treatment should be considered in each case. Patients should be regularly evaluated for bleeding risks and thrombotic complications.
Asunto(s)
Trastornos de la Coagulación Sanguínea/sangre; COVID-19/sangre; Embolia/sangre; Trombosis/sangre; Anticoagulantes/uso terapéutico; Trastornos de la Coagulación Sanguínea/tratamiento farmacológico; Trastornos de la Coagulación Sanguínea/etiología; Trastornos de la Coagulación Sanguínea/metabolismo; COVID-19/complicaciones; COVID-19/metabolismo; Síndrome de Liberación de Citoquinas/sangre; Síndrome de Liberación de Citoquinas/complicaciones; Síndrome de Liberación de Citoquinas/metabolismo; Coagulación Intravascular Diseminada/sangre; Coagulación Intravascular Diseminada/etiología; Coagulación Intravascular Diseminada/metabolismo; Coagulación Intravascular Diseminada/prevención & control; Embolia/etiología; Embolia/metabolismo; Embolia/prevención & control; Endotelio Vascular/metabolismo; Productos de Degradación de Fibrina-Fibrinógeno/metabolismo; Fibrinógeno/metabolismo; Humanos; Hipoxia/sangre; Hipoxia/etiología; Hipoxia/metabolismo; Inmovilización; Inflamación/sangre; Inflamación/etiología; Inflamación/metabolismo; Accidente Cerebrovascular Isquémico/sangre; Accidente Cerebrovascular Isquémico/etiología; Accidente Cerebrovascular Isquémico/metabolismo; Accidente Cerebrovascular Isquémico/prevención & control; Infarto del Miocardio/sangre; Infarto del Miocardio/etiología; Infarto del Miocardio/metabolismo; Infarto del Miocardio/prevención & control; Guías de Práctica Clínica como Asunto; Embolia Pulmonar/sangre; Embolia Pulmonar/etiología; Embolia Pulmonar/metabolismo; Embolia Pulmonar/prevención & control; Índice de Severidad de la Enfermedad; Trombocitopenia/sangre; Trombocitopenia/etiología; Trombosis/etiología; Trombosis/metabolismo; Trombosis/prevención & control; Trombosis de la Vena/sangre; Trombosis de la Vena/etiología; Trombosis de la Vena/metabolismo; Trombosis de la Vena/prevención & control

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Trombosis / Trastornos de la Coagulación Sanguínea / Embolia / COVID-19 Tipo de estudio: Estudio experimental / Estudio observacional / Estudio pronóstico Tópicos: Covid persistente Idioma: Inglés Revista: Cardiol Rev Asunto de la revista: Angiología / Cardiología Año: 2021 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Trombosis / Trastornos de la Coagulación Sanguínea / Embolia / COVID-19 Tipo de estudio: Estudio experimental / Estudio observacional / Estudio pronóstico Tópicos: Covid persistente Idioma: Inglés Revista: Cardiol Rev Asunto de la revista: Angiología / Cardiología Año: 2021 Tipo del documento: Artículo